These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 17006433
21. Effects of acute Δ9-tetrahydrocannabinol on next-day extinction recall is mediated by post-extinction resting-state brain dynamics. Rabinak CA, Peters C, Marusak HA, Ghosh S, Phan KL. Neuropharmacology; 2018 Dec; 143():289-298. PubMed ID: 30291940 [Abstract] [Full Text] [Related]
22. A study investigating the acute dose-response effects of 13 mg and 17 mg Delta 9- tetrahydrocannabinol on cognitive-motor skills, subjective and autonomic measures in regular users of marijuana. Weinstein A, Brickner O, Lerman H, Greemland M, Bloch M, Lester H, Chisin R, Sarne Y, Mechoulam R, Bar-Hamburger R, Freedman N, Even-Sapir E. J Psychopharmacol; 2008 Jun; 22(4):441-51. PubMed ID: 18635724 [Abstract] [Full Text] [Related]
23. Cannabinoid Modulation of Frontolimbic Activation and Connectivity During Volitional Regulation of Negative Affect. Gorka SM, Phan KL, Lyons M, Mori S, Angstadt M, Rabinak CA. Neuropsychopharmacology; 2016 Jun; 41(7):1888-96. PubMed ID: 26647971 [Abstract] [Full Text] [Related]
25. Assessment of driving capability through the use of clinical and psychomotor tests in relation to blood cannabinoids levels following oral administration of 20 mg dronabinol or of a cannabis decoction made with 20 or 60 mg Delta9-THC. Ménétrey A, Augsburger M, Favrat B, Pin MA, Rothuizen LE, Appenzeller M, Buclin T, Mangin P, Giroud C. J Anal Toxicol; 2005 Jun; 29(5):327-38. PubMed ID: 16105257 [Abstract] [Full Text] [Related]
26. Brain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix. Walter C, Oertel BG, Felden L, Kell CA, Nöth U, Vermehren J, Kaiser J, Deichmann R, Lötsch J. Neuropsychopharmacology; 2016 May; 41(6):1659-69. PubMed ID: 26514581 [Abstract] [Full Text] [Related]
28. The effects of insula damage on decision-making for risky gains and losses. Weller JA, Levin IP, Shiv B, Bechara A. Soc Neurosci; 2009 May; 4(4):347-58. PubMed ID: 19466680 [Abstract] [Full Text] [Related]
31. The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial. Englund A, Atakan Z, Kralj A, Tunstall N, Murray R, Morrison P. J Psychopharmacol; 2016 Feb; 30(2):140-51. PubMed ID: 26577065 [Abstract] [Full Text] [Related]
37. Lack of hippocampal CB1 receptor desensitization by Δ(9)-tetrahydrocannabinol in aged mice and by low doses of JZL 184. Feliszek M, Bindila L, Lutz B, Zimmer A, Bilkei-Gorzo A, Schlicker E. Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):603-12. PubMed ID: 26984820 [Abstract] [Full Text] [Related]
39. Acute effects of ∆9-tetrahydrocannabinol (THC) on resting state brain function and their modulation by COMT genotype. Bossong MG, van Hell HH, Schubart CD, van Saane W, Iseger TA, Jager G, van Osch MJP, Jansma JM, Kahn RS, Boks MP, Ramsey NF. Eur Neuropsychopharmacol; 2019 Jun; 29(6):766-776. PubMed ID: 30975584 [Abstract] [Full Text] [Related]